脂蛋白(a)及胆红素检验对冠心病的诊断价值研究

Diagnostic Value of Lipoprotein (a) and Bilirubin Test in Coronary Heart Disease

目的:研究分析对冠心病采用脂蛋白(a)以及胆红素检验的临床诊断价值。方法:选取2015年11月～2017年11月某院接收的102例冠心病患者为此次研究对象定义为研究组,并同期选择健康体检群体102例定义为参照组,两组均予以脂蛋白(a)以及胆红素检验,比较两组脂蛋白(a)以及胆红素水平。结果:比较分析,研究组总胆红素水平要低于参照组,差异具有统计学意义(P<0.05);研究组直接胆红素水平以及间接胆红素水平与参照组比较无差异,不具有统计学意义(P>0.05);同时研究组脂蛋白(a)水平,要高于参照组,差异有统计学意义(P<0.05)。结论:冠心病患者的脂蛋白(a)水平较高,总胆红素水平较低,能够作为临床诊断的参考依据之一,值得临床推广应用。

Objective: To study and analyze the clinical diagnostic value of lipoprotein(a) and bilirubin test in coronary heart disease(CHD). Methods: 102 patients with coronary heart disease in a hospital from November 2015 to November 2017 were selected as the study group, and 102 healthy people at the same period were selected as the reference group. Lipoprotein(a) and bilirubin were tested in both groups, and the levels of lipoprotein(a) and bilirubin were compared between the two groups. Results: The level of total bilirubin in the study group was lower than that in the reference group, the difference was statistically significant(P<0.05), the direct and indirect bilirubin levels in the study group were not significantly different from those in the control group(P>0.05). At the same time, lipoprotein(a) level in the study group was higher than that in the control group, and the difference was statistically significant(P<0.05). Conclusion: Patients with coronary heart disease have higher lipoprotein(a) level and lower total bilirubin level, which can be used as a reference for clinical diagnosis and is worthy of clinical application.